?? did ???????????????? ???? ?????????????? ???????????????? – ?????? ?????? ????’?? ???????????? ???? ????????????
Dr Namrata Upadhyay ??
I'm In The Business Of SMILES?Connecting Dental Companies w/ KOLs, Freelancers & Early Adopters | Training Dentists On Medical Devices | Dentist, MedTech Consultant & Board Advisor | Stubborn Optimist Who ?? Authenticity
It's Europe's last year with Amalgam Dental Fillings
?????????????????? ?????? ???????????????? ??????????????????, ???????????? ?????? ???????????????????? ???????????? ?????????????? dental ????????????????, ???? ???? ?????????????????? ???????? ?????? ????????.
As of today - It’s rare that you come across people who haven’t gotten their teeth filled with amalgam or know somebody who has. These teeth have a silvery hue to them because it has mercury in it.
Amalgam fillings were the standard of care & still are in many countries worldwide
?????????? ???? ???????? - as a dentist, it was never comfortable to work with mercury and knowingly place amalgam in a patient’s tooth, but all students were informed that it’s “Safe”. It weird as hell though.
In my case, for the hundreds of patients that I treated, working at a busy government hospital in India - most of whom had travelled many miles from rural areas to receive treatment – it was the only option they could afford.
I wonder now, in complete agreement with this long due ban, yet wondering what would those rural patients be offered, had India introduced this ban? The one’s who can’t afford expensive restorative material options – this would surely impact oral health care prevention efforts negatively.
Would such a ban even work in countries like India?
Needless to say, I was not surprised at all when I was at the university of Ljubljana, Slovenia, to see composite fillings as a common offering to patients. So perhaps it’s not that bad in Europe?
Such paradoxes exist in plenty in the medical practice world. And medical/dental students are at the behest of their seniors and professors to teach them the standard of care.
But thanks to continued innovation & efforts to make devices and materials affordable, plus evidence based practices, one has hope that safer alternatives will supersede more risky legacy devices/materials in the long run, to make healthcare safer.
With the caveat that large conglomerates abide to ensuring that Device Risk:Benefit ratio discussions takes precedence over Business Profits.
If not, the law eventually catches up.
Which leads to 2 questions for my LinkedIn circle:
Q1:?If you’ve received amalgam fillings or know older friends and family who have, would you agree to ban standard of care devices/materials - that have data showing more living people than dead - with not sufficient data to state mercury poisoning as a cause of death to the ones that passed away.?Would you have a tendency to see such a ruling as an over-reaction or a just decision?
Q2:?More interestingly, if you sat on the #Board?of such a manufacturer, who’s core revenue is generated from Amalgam sales,?would you knowingly ask them to move business to markets where it isn’t banned? Would you judge it as ethical knowing what you now know?
The answers to these 2 questions help open up the discussion to how different humans approach medical/dental devices and materials.
Does a long lasting market presence supersede latest scientific findings or vice versa?
Author Profile:
Dr Namrata Upadhyay is a dental surgeon and an experienced clinical and regulatory consultant in the MedTech space, with expertise in EU regulatory strategy, document creation and submissions. She has honed the hats of being clinical study monitor, safety reporting manager, Chief Medical Officer and VP marketing for a DenTech startup, freelance consultant, medical writer and . As the CEO and founder of NamNRPro, she guides Dental Tech teams to flow better and together, by bringing the World's first Global Dentists' Pool, an Upwork-like platform that supports dental R&D, clinical, marketing and sales team collaborate directly with multi-faced dentists who bring both clinical and corporate experience.
Venture Builder & Investor with a focus on AI startups
9 个月I guess my question would be why not push for advancements towards safer, more mass produceable composite fillings? We can't control what's already being done to an extent, but its a similar question to climate change. We have to quantify what's being done currently as well as the risk, understand what it would take to move forward and what that would mean for the business, and if we think it worthwhile for our business. Typically not adjusting means business death, so there's those thoughts to consider as well.
Visionary Thought Leader??Top Voice 2024 Overall??Awarded Top Global Leader 2024??CEO | Board Member | Executive Coach Keynote Speaker| 21 X Top Leadership Voice LinkedIn |Relationship Builder| Integrity | Accountability
9 个月The move away from amalgam fillings reflects a broader trend towards #safer, more #sustainable medical and dental practices. While the transition poses challenges regarding accessibility and affordability in less affluent regions, it also opens up opportunities for innovation and improvement in dental care materials. The ethical considerations for manufacturers highlight the importance of aligning business practices with global health and environmental standards. Ultimately, the phasedown of amalgam fillings could catalyze the development of new materials that are both effective and safe, benefiting patients worldwide. Thank you for sharing Dr. Namrata Upadhyay and highlighting this critical issue. #sustainability #ethicalleadership #development
I'm In The Business Of SMILES?Connecting Dental Companies w/ KOLs, Freelancers & Early Adopters | Training Dentists On Medical Devices | Dentist, MedTech Consultant & Board Advisor | Stubborn Optimist Who ?? Authenticity
9 个月Here's a question for all of you - curious to know how you would address it as Board members: If you're a Board member at a company who's portfolio includes dental materials, including amalgam, and the data now cites both sides of the spectrum ie. amalgam is extremely dangerous vs amalgam is safe. If the Board mandate is that company growth & profit is the core focus, then in light of this ban - considering that amalgam is a heavy revenue generator for this company - would you change the mandate, on grounds of ethics, and cite that all amalgam sales should be halted immediately (irrespective of whether or not alternate regions still approve its sales) and the company should alternatively start vamping up other dental materials in its portfolio (which are still on the market?) or keep it alive in the markets where you can still sell it and start planning alternate product scale ups? - Indira B., Michel Haddad, Michelle Clarke, Brad Messer, Callum Laing, Michele Barbazza, Sanjay Roye, Arvashni Seeripat, James Rose, Ferdie Bruijnen, Nam Phong Ho, Francisco Gaffney, Paul Langshaw, Ralph White, Graham Mulligan, Payal Walker #Boardfoodforthought